Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
76.16
+0.66 (0.87%)
Aug 12, 2026, 11:51 AM EDT - Market open
Nektar Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -158.1 | -164.08 | -118.96 | -276.06 | -368.2 | -523.84 |
Depreciation & Amortization | 0.75 | 1.03 | 4.39 | 7.82 | 13.03 | 14.15 |
Stock-Based Compensation | 12.11 | 12.65 | 21.61 | 33.39 | 57.32 | 94.67 |
Other Adjustments | -26.02 | -21.09 | -76.51 | 62.19 | -6.65 | 25.33 |
Change in Receivables | - | - | -3.05 | 4.78 | 16.51 | 12.4 |
Changes in Inventories | - | - | 0.5 | 0.7 | -3.4 | -0.51 |
Changes in Accounts Payable | -7.97 | -0.63 | 2.67 | -2.88 | 3.1 | -11.69 |
Changes in Accrued Expenses | -4.67 | -5.79 | 10.73 | -17.26 | -19.95 | -22.93 |
Changes in Other Operating Activities | -24.3 | -30.61 | -17.09 | -5.27 | 4.23 | -0.25 |
Operating Cash Flow | -203.76 | -208.51 | -175.71 | -192.61 | -304.01 | -412.66 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -0.19 | -0.17 | -1.47 | -0.87 | -5.68 | -14.99 |
Sale of Property, Plant & Equipment | - | - | - | 1.25 | 13.2 | - |
Purchases of Investments | -712.33 | -285.01 | -261.71 | -511.7 | -467.91 | -960.69 |
Proceeds from Sale of Investments | 316.85 | 284.68 | 340.36 | 650.88 | 826.23 | 1,178 |
Proceeds from Business Divestments | - | -0.7 | 65.39 | - | - | - |
Investing Cash Flow | -395.68 | -1.2 | 142.57 | 139.56 | 365.84 | 202.78 |
Long-Term Debt Issued | - | - | 15 | - | - | - |
Net Long-Term Debt Issued (Repaid) | - | - | 15 | - | - | - |
Issuance of Common Stock | 4.91 | 181.72 | 30.12 | 0.03 | 0.76 | 33.24 |
Repurchase of Common Stock | - | - | -3 | - | - | - |
Net Common Stock Issued (Repurchased) | 4.91 | 181.72 | 27.12 | 0.03 | 0.76 | 33.24 |
Other Financing Activities | - | -1.15 | - | - | 0.75 | 3 |
Financing Cash Flow | 710.11 | 180.57 | 42.12 | 0.03 | 1.51 | 36.24 |
Foreign Exchange Rate Adjustments | 0.01 | 0.01 | -0 | 0.06 | -0.33 | -0.09 |
Net Cash Flow | 110.68 | -29.14 | 8.98 | -52.95 | 63.01 | -173.74 |
Free Cash Flow | -203.94 | -208.68 | -177.18 | -193.47 | -309.68 | -427.65 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -366.59% | -377.83% | -180.01% | -214.68% | -336.41% | -419.65% |
Free Cash Flow Per Share | -10.45 | -12.37 | -12.92 | -15.27 | -24.82 | -35.00 |
Levered Free Cash Flow | -194.47 | -200.24 | -104.23 | -293.82 | -376.86 | -560.05 |
Unlevered Free Cash Flow | -170.88 | -176.14 | -105.26 | -281.26 | -388.14 | -482.79 |